New obesity shot tested in humans for first time
NCT ID NCT06640647
Summary
This was an early safety study of a new injectable drug called HDM1005, designed to help with weight management. It tested single doses in 65 healthy adults to check for side effects and see how the body processes the drug. Researchers also looked for early signs of its effect on body weight and blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, China
Conditions
Explore the condition pages connected to this study.